港股異動 | 保利置業(00119.HK)放量跌逾6% 存貨撥備計提8億元
格隆匯1月15日丨保利置業集團(00119.HK)今日股價明顯放量下跌。現報3.23港元,跌6.65%,暫成交6153萬港元,最新總市值118.27億港元。

保利置業集團(00119.HK)預期2019年淨利潤同比增長不少於60%,公司股東應占淨利潤的預期增長主要源自一項香港開發項目結轉利潤。
值得注意的是,公司中期業績靚麗,但下半年貴州區域車位平均售價下跌,計提人民幣8億元的存貨撥備,將影響全年業績表現。
業內人士稱,公司質地優良,雖存貨撥備但業績表現依舊亮眼,惟近期股價陸續上漲有回吐需求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.